Skip to main content
. 2016 Apr 26;7(23):34907–34917. doi: 10.18632/oncotarget.8995

Figure 2. Serum OPG levels and PFS.

Figure 2

Patients were separated into cases with (solid line) or without (dashed line) increase in circulating OPG levels from baseline to completion of induction neoadjuvant chemotherapy, as measured by the single-parameter immunoassay. The difference between the two groups was significant (log-rank test; P = 0.009).